Choose your Language

LogIn

Some areas of this website are accessible to registered members only.

If you have no account yet, please click on "Register".
If you have forgotten your password, please click on "Forgot login?".



 

Welcome to the European Patients' Academy Expert Training Course for Patients and Patient Representatives on the Medicines Research & Development Process.

academic.svg.hiThe EUPATI Expert Training Course is an exciting and unique opportunity offering patients and patient advocates expert-level training in medicines research and development. The Course is a mixture of independent e-learning coursework and face-to-face training events over a 14-month period. The first Course cycle kicked off in October 2014 and will run until December 2015. 

The second cycle of the EUPATI Expert Training Course is set to be launched in September 2015 running until the end of November 2016. 60 Course participants will be chosen by an independent selection panel on the basis of predefined selection criteria. For this Course, selected trainees must commit to at least 250 hours of e-learning study and 8-10 days (including travel) to attend face-to-face training sessions. Upon completion of the Course, trainees will have the knowledge to make meaningful contributions to patient empowerment and advocacy and to contribute to the broader dialogue on patient involvement in medicines research and development across Europe. 

Applications are no longer being accepted for the 2015-2016 Course. The deadline for submitting applications was 31 March 2015 (23:59 Central European Time). 

All applicants will receive notification via email by 5 July 2015 to confirm if they have been successful or not. Please refrain from making inquiries on the status of your application - if you do not hear from us by 6 July, feel free to contact Danielle Flores at EPF at: This email address is being protected from spambots. You need JavaScript enabled to view it.

To learn a bit more about EUPATI and the Course, please watch this video of Nicola Bedlington, Secretary General of the European Patients' Forum (EPF) and Coordinator of EUPATI. Her speech outlines why it is essential that patient advocates become qualified partners in medicines research and development to improve patient outcomes.

In case of any questions, please contact Danielle Flores, Policy and Programme Assistant at the European Patients' Forum at : This email address is being protected from spambots. You need JavaScript enabled to view it.